Patent · US Active

LIMK2 inhibitors, compositions comprising them, and methods of their use

US8193202B2 · kind B2 · utility

2Cited by

9References

7Claims

0Family size

Assignee

LEXICON PHARMACEUTICALS, INC. · US

Inventors

Hugh Alfred Burgoon · Hillsborough Township, US
Nicole Cathleen Goodwin · Pennington, US
Bryce A. Harrison · Framingham, US
Jason Healy · Monmouth Junction, US
Ying Liu · Lawrenceville, US
Ross Mabon · Lambertville, US
Brett Marinelli · Hillsborough Township, US
David Brent Rawlins · Levittown, US
Dennis Stewart Rice · Diemelstraße, US
Norris Andrew Whitlock · Diemelstraße, US

Key dates

Filing date	Apr 20, 2009
Grant date	Jun 5, 2012
Priority date	—
Expiry date	Dec 31, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of LIM kinase 2 are disclosed, along with pharmaceutical compositions comprising them and methods of their use. Particular compounds are of the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.